By Toni Clarke WASHINGTON (Reuters) - Financial incentives and a more flexible regulatory approach are needed to persuade drug companies to develop new antibiotics, drug industry and public health experts told U.S. lawmakers on Friday, though some warned that modifying the drug approval process could jeopardize patient safety. The experts said at a hearing of the U.S. ...
via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment